retatrutide austin tx 9/17/25 Wellness & Aesthetics Orientation: The Next Generation of Weight Loss – & Emerging Treatments & San Antonio, Retatrutide at Le Chloé Med

Regular check-ins allow for better tracking of progress and possible issues

Phase 2 trial data (NEJM, 2023) reported a mean body weight reduction of approximately 24% over 48 weeks at the highest dose, though larger Phase 3 trials are needed to confirm these findings

Predictions on New Indications and Formulations Thinking about how tirzepatide will impact the drug industry gives us positive expectations

Comparing retatrutide skin effects to other GLP-1 medications If you are considering switching between GLP-1 medications due to skin sensitivity, understanding the comparative landscape helps inform that decision

Patients treated with insulin including SEMGLEE, and a PPAR-gamma agonist should be observed for signs and symptoms of heart failure

Several studies have examined the potential effects of GLP-1 RAs in SIH and SID